Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy: a multicentre, parallel, randomised, controlled, phase 3 trial
The Lancet. Respiratory medicine, vol. 10, no. 6, pp. 584-592
Contributions to Journals: Articles
- Digital Object Identifier
- https://doi.org/10.1016/S2213-2600(21)00486-0
- Open Access
- http://aura.abdn.ac.uk/bitstreams/fbfe9e9f-1895-4334-8b3b-800ff820d194/download
- Additional Links
- View publication in Scopus